These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 36729885)

  • 1. Engagement in Online Communities by New Mothers in Recovery from Opioid Use Disorder.
    Mattson NM; Ohlendorf JM
    MCN Am J Matern Child Nurs; 2023 Mar-Apr 01; 48(2):82-87. PubMed ID: 36729885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Primary Care in Improving Access to Medication-Assisted Treatment for Rural Medicaid Enrollees with Opioid Use Disorder.
    Cole ES; DiDomenico E; Cochran G; Gordon AJ; Gellad WF; Pringle J; Warwick J; Chang CH; Kim JY; Kmiec J; Kelley D; Donohue JM
    J Gen Intern Med; 2019 Jun; 34(6):936-943. PubMed ID: 30887440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addressing opioid use disorder among rural pregnant and postpartum women: a study protocol.
    Bryan MA; Smid MC; Cheng M; Fortenberry KT; Kenney A; Muniyappa B; Pendergrass D; Gordon AJ; Cochran G
    Addict Sci Clin Pract; 2020 Oct; 15(1):33. PubMed ID: 33129355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-Reported Goals of Youths in Canada Receiving Medication-Assisted Treatment for Opioid Use Disorder.
    Chai D; Rosic T; Panesar B; Sanger N; van Reekum EA; Marsh DC; Worster A; Thabane L; Samaan Z
    JAMA Netw Open; 2021 Aug; 4(8):e2119600. PubMed ID: 34351402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal intent and postpartum receipt of long-acting reversible contraception among women receiving medication-assisted treatment for opioid use disorder.
    Kotha A; Chen BA; Lewis L; Dunn S; Himes KP; Krans EE
    Contraception; 2019 Jan; 99(1):36-41. PubMed ID: 30114393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doula engagement and maternal opioid use disorder (OUD): Experiences of women in OUD recovery during the perinatal period.
    Gannon M; Short V; Becker M; Parikh S; McGuigan K; Hand D; Keith S; Abatemarco D
    Midwifery; 2022 Mar; 106():103243. PubMed ID: 34999514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A statewide quality improvement (QI) initiative for better health outcomes and family stability among pregnant women with opioid use disorder (OUD) and their infants.
    Crane D; Marcotte M; Applegate M; Massatti R; Hurst M; Menegay M; Mauk R; Williams S
    J Subst Abuse Treat; 2019 Jul; 102():53-59. PubMed ID: 31202289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal and infant characteristics associated with maternal opioid overdose in the year following delivery.
    Nielsen T; Bernson D; Terplan M; Wakeman SE; Yule AM; Mehta PK; Bharel M; Diop H; Taveras EM; Wilens TE; Schiff DM
    Addiction; 2020 Feb; 115(2):291-301. PubMed ID: 31692133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engagement in perinatal outpatient services among women in recovery from opioid use disorders.
    Peacock-Chambers E; Paterno MT; Kiely D; Fioroni T; Byatt N; Friedmann PD
    Subst Abus; 2021; 42(4):1022-1029. PubMed ID: 33798013
    [No Abstract]   [Full Text] [Related]  

  • 10. Review of medication-assisted treatment for opioid use disorder.
    Ghanem N; Dromgoole D; Hussein A; Jermyn RT
    J Osteopath Med; 2022 Mar; 122(7):367-374. PubMed ID: 35285220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eight-hour medication-assisted treatment waiver training for opioid use disorder: integration into medical school curriculum.
    Lien IC; Seaton R; Szpytman A; Chou J; Webber V; Waineo E; Levine D
    Med Educ Online; 2021 Dec; 26(1):1847755. PubMed ID: 33222656
    [No Abstract]   [Full Text] [Related]  

  • 12. Rural access to MAT in Pennsylvania (RAMP): a hybrid implementation study protocol for medication assisted treatment adoption among rural primary care providers.
    Cochran G; Cole ES; Warwick J; Donohue JM; Gordon AJ; Gellad WF; Bear T; Kelley D; DiDomenico E; Pringle J
    Addict Sci Clin Pract; 2019 Aug; 14(1):25. PubMed ID: 31366408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MATernaL and Infant NetworK to Understand Outcomes Associated with Treatment of Opioid Use Disorder During Pregnancy (MAT-LINK): Surveillance Opportunity.
    Tran EL; Kim SY; England LJ; Green C; Dang EP; Broussard CS; Fehrenbach N; Hudson A; Yowe-Conley T; Gilboa SM; Meaney-Delman D
    J Womens Health (Larchmt); 2020 Dec; 29(12):1491-1499. PubMed ID: 33227221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of Medicaid expansion on postpartum health care utilization among pregnant women with opioid use disorder.
    Patton BP; Krans EE; Kim JY; Jarlenski M
    Subst Abus; 2019; 40(3):371-377. PubMed ID: 30908175
    [No Abstract]   [Full Text] [Related]  

  • 15. Coordinating Outpatient Care for Pregnant and Postpartum Women with Opioid Use Disorder: Implications from the COACHH Program.
    Hodgins FE; Lang JM; Malseptic GG; Melby LH; Connolly KA
    Matern Child Health J; 2019 May; 23(5):585-591. PubMed ID: 30604105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of neonatal outcomes in pregnant women undergoing medication-assisted treatment of opioid use disorder with methadone or buprenorphine/naloxone.
    Petrich M; Battin M; Walker E; Brown M; Abdelwahab M; Ma'ayeh M; Rood KM
    J Matern Fetal Neonatal Med; 2022 Dec; 35(26):10481-10486. PubMed ID: 36202398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming Barriers: Individual Experiences Obtaining Medication-Assisted Treatment for Opioid Use Disorder.
    Scorsone KL; Haozous EA; Hayes L; Cox KJ
    Qual Health Res; 2020 Nov; 30(13):2103-2117. PubMed ID: 32691670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled trial of an intervention to reduce stigma toward people with opioid use disorder among primary care clinicians.
    Hooker SA; Crain AL; LaFrance AB; Kane S; Fokuo JK; Bart G; Rossom RC
    Addict Sci Clin Pract; 2023 Feb; 18(1):10. PubMed ID: 36774521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Substance Use, Recovery, and Non-Drug-Related Online Community Participation on the Risk of a Use Episode During Remission From Opioid Use Disorder: Longitudinal Observational Study.
    Naserianhanzaei E; Koschate-Reis M
    J Med Internet Res; 2022 Aug; 24(8):e36555. PubMed ID: 35994333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid Use Disorder and Perinatal Outcomes.
    Piske M; Homayra F; Min JE; Zhou H; Marchand C; Mead A; Ng J; Woolner M; Nosyk B
    Pediatrics; 2021 Oct; 148(4):. PubMed ID: 34479983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.